The dream of a healthy life for everyone inspires us every day.
Recent breakthroughs in biochemistry and genomics bring us closer to achieving this dream. As new and established firms explore these advances, the potential for innovative therapeutic interventions grows exponentially. These advancements promise significant impacts on cancer, neurological diseases, autoimmune disorders, and infectious diseases.
In this rapidly evolving field, bio-pharmaceutical and medical device companies must stay at the forefront of scientific and market developments while ensuring efficient, regulatory-compliant operations.
Pienomial's AI-powered platform, Knolens, transforms vast, diverse data into clear, actionable intelligence. Our platform's real-time data analysis and scenario modeling eliminate human error and deliver unique insights, empowering decision-makers with clarity and precision.
We serve the entire biopharmaceutical value chain, from drug development to delivery. By leveraging state-of-the-art machine learning and generative AI technologies, Pienomial provides the latest scientific and market intelligence, ensuring our customers stay competitive.
Our solutions also optimize operational processes to meet and exceed regulatory standards, helping avoid costly recalls and protecting brand reputation.
Meet the Team
Dr. Sanat Mohanty
Co-Founder and CEO
Executive Leadership in Biotech & Medical Devices Industry
Omkar Patil
Chief Technology Officer
10+ years in Technology & Product Development
Srinivas P.
Chief Product Officer
25+ years in IT Product Mgmt & Services Delivery
USA Office
Pienomial, 1 Research Court, Suite 450, Rockville, MD 20850
India Office
Warje, Pune
Ready to unlock the full potential of your Life Sciences Data?
Contact us today for a personalized demo and discover how our AI Platform can accelerate your product development lifecycle efforts.
